Nutcracker Therapeutics IPO

nutcrackerx.com

Nutcracker Therapeutics develops a platform to enable the development and manufacturing of all RNA therapeutics.

Founded2017
Total Funding to Date$243.3MM
Register for Details

For more details on financing and valuation for Nutcracker Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Nutcracker Therapeutics Ticker Symbol

Nutcracker Therapeutics does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

Nutcracker Therapeutics Stock Price

The stock price for Nutcracker Therapeutics will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Nutcracker Therapeutics Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
3/14/2022 Series C $993.11MM $XXX.XX $XXX.XX
9/23/2020 Series B $161.22MM $XXX.XX $XXX.XX
3/11/2019 Series A $104.46MM $XXX.XX $XXX.XX
4/30/2018 Series Seed $5.33MM $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Other companies like Nutcracker Therapeutics in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$317.32MM
Sector
 
 
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$334.19MM